Literature DB >> 26076627

Formulation and evaluation of nanocrystalline cellulose as a potential disintegrant.

Chengyu Wang1, Huijin Huang1, Min Jia1, Shanshan Jin1, Wenjing Zhao1, Ruitao Cha2.   

Abstract

Disintegrant is a typical excipient that improves the solubility, dissolution and bioavailability of drug. In this study, the application of nanocrystalline cellulose (NCC) as a potential disintegrant in the preparation of tablet was investigated. Angle of repose of NCC was 44.26° which was between L-HPC and MCC suggesting a good fluidity of NCC. Swelling property of NCC was between CMS-Na and MCC indicating that NCC was of good absorbent ability. Carbonate calcium tablet of which NCC was used as a disintegrant exhibited fastest disintegration time than known disintegrants. The disintegration and dissolution tests demonstrated that NCC showed effective disintegrant properties, e.g. consistently fast disintegration, rapid dissolution, and effectiveness at low concentrations. Thus, we believe that NCC has a great potential as a disintegrant in tablets.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Disintegrant; Disintegration time; Nanocrystalline cellulose

Mesh:

Substances:

Year:  2015        PMID: 26076627     DOI: 10.1016/j.carbpol.2015.05.007

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  2 in total

1.  Cellulose Nanocrystal Membranes as Excipients for Drug Delivery Systems.

Authors:  Ananda M Barbosa; Eduardo Robles; Juliana S Ribeiro; Rafael G Lund; Neftali L V Carreño; Jalel Labidi
Journal:  Materials (Basel)       Date:  2016-12-12       Impact factor: 3.623

2.  Similarity Evaluation on the Compound TCM Formulation "Huoling Shengji Granule" and Its Placebo by Intelligent Sensory Evaluation Technologies and the Human Sensory Evaluation Method Based on Critical Quality Attributes.

Authors:  Mei Wu; Chengjie Guo; Ning Guo; Tianyi Zhang; Youjie Wang; Yuan Wang; Xiao Lin; Fei Wu; Yi Feng
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-14       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.